{"id":616308,"date":"2022-09-14T20:32:01","date_gmt":"2022-09-14T20:32:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=616308"},"modified":"2022-09-14T20:32:01","modified_gmt":"2022-09-14T20:32:01","slug":"openangle-glaucoma-market-to-register-incremental-growth-during-the-forecast-period-2032-asserts-delveinsight-key-companies-graybug-annexon-polyactiva-aerpio-salvat-qlaris-bio-nicox","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/openangle-glaucoma-market-to-register-incremental-growth-during-the-forecast-period-2032-asserts-delveinsight-key-companies-graybug-annexon-polyactiva-aerpio-salvat-qlaris-bio-nicox_616308.html","title":{"rendered":"Open-Angle Glaucoma Market to Register Incremental Growth During the Forecast Period 2032, Asserts DelveInsight | Key Companies – GrayBug, Annexon, PolyActiva, Aerpio, SALVAT, Qlaris Bio, Nicox"},"content":{"rendered":"
\n
\"Open-Angle<\/a><\/div>\n
\n
Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
As per DelveInsight\u2019s assessment, globally, there are 20+ companies working on 20+ pipeline drugs in the Open-Angle Glaucoma therapeutics landscape. The Open-Angle Glaucoma market size is expected to increase immensely in the coming years owing to the expected launch of potential therapies and increasing awareness among the general population about the disease.<\/div>\n

DelveInsight’s “Open-Angle Glaucoma Market Insights, Epidemiology, and Market Forecast 2032<\/strong>” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Open-Angle Glaucoma Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/p>\n

The Open-Angle Glaucoma market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/p>\n

\"Open-Angle<\/p>\n

Open-Angle Glaucoma: An Overview<\/strong><\/p>\n

Glaucoma describes a group of conditions in which there is characteristic cupping of the optic disc with corresponding visual field defects, due to retinal ganglion cell loss. It is a progressive condition and the most common cause of irreversible blindness worldwide. The two major categories of glaucoma are open-angle glaucoma (OAG) and narrow-angle glaucoma.<\/p>\n

The OAG is primarily divided into two subtypes, i.e., Primary open-angle glaucoma (POAG) and Secondary open-angle glaucoma. POAG is a subset of glaucoma defined by an open, normal-appearing anterior chamber angle and raised intraocular pressure (IOP), with no other underlying disease. In Secondary open-angle glaucoma, there is an identifiable cause of increased eye pressure, resulting in optic nerve damage and vision loss.<\/em><\/p>\n

Open-Angle Glaucoma Market Key Facts<\/strong><\/p>\n